These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 317647)

  • 21. [Autovaccination in chronic pyelonephritis in the animal experiment--effect of cyclophosphamide on splenic and thymus lymphocytes].
    Straube E; Schütt W
    Z Urol Nephrol; 1987 Aug; 80(8):483-90. PubMed ID: 3318218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of immunocompetence assays for defining immunosuppression.
    Dean JH; Padarathsingh ML; Jerrells TR
    Ann N Y Acad Sci; 1979 May; 320():579-90. PubMed ID: 110201
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes induced by cyclophosphamide in mice immune response to sheep red blood cells].
    Giovanniello OA; Barrios HA; Rondinone SN; Nota NR
    Medicina (B Aires); 1983; 43(3):301-7. PubMed ID: 6672512
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular immunity in experimental fungus infections in mice: the influence of infections and treatment with a Candida toxin on spleen lymphoid cells.
    Iwata K; Uchida K
    Mykosen Suppl; 1978; 1():72-81. PubMed ID: 318139
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential asparaginase sensitivity of T-cell and B-cell responses.
    Berenbaum MC; Cope WA; Jeffery W
    Clin Exp Immunol; 1973 Dec; 15(4):565-72. PubMed ID: 4591641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.
    Gao C; Jiang J; Ma P; Cheng P; Lian Y; Zhao B; Li C; Peng Y; Wang F; Lin Y; Jin N; Li J; Wang L; Li Q; Leng Y; Xia J; Qi Z
    Transplantation; 2015 Sep; 99(9):1796-806. PubMed ID: 25919768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ICRF 159 on immune responses.
    Hellmann K
    Proc R Soc Med; 1972 Mar; 65(3):264-5. PubMed ID: 4563302
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of anesthesia on the immune system].
    Stoianov E; Gencheva G
    Khirurgiia (Sofiia); 1982; 35(3):259-65. PubMed ID: 6750218
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of synthetic homoribopolynucleotide complexes on the immune response.
    Cone RE
    Pharmacol Ther; 1980; 8(2):321-37. PubMed ID: 6992157
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cytostatic activity of macrophages against MOPC-315 tumour cells by combined cyclophosphamide administration and immunisation with glutaraldehyde-treated tumour cells.
    Ophir R; Ben-Efraim S; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):175-80. PubMed ID: 6241828
    [No Abstract]   [Full Text] [Related]  

  • 38. [Functional activity of T and B lymphocytes of mice undergoing spontaneous loss of tolerance].
    Kondrat'eva IA; Novikova TK; Fontalin LN
    Biull Eksp Biol Med; 1979 Sep; 88(9):314-7. PubMed ID: 316340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunopharmacology of cyclophosphamide.
    Shand FL
    Int J Immunopharmacol; 1979; 1(3):165-71. PubMed ID: 399479
    [No Abstract]   [Full Text] [Related]  

  • 40. An active suppressor mechanism preventing skin allograft rejection in mice.
    Kilshaw PJ; Brent L; Pinto M
    Transplant Proc; 1975 Jun; 7(2):225-8. PubMed ID: 48301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.